Financing: Six, Va-Q-Tec, Mytheresa – FINANCE Magazin
The biotech company Atai Life Sciences has closed a Series C financing round of $ 125 million. Lead investors were the Apeiron Investment Group as well as Peter Thiel and Catalio Capital Management. Future Ventures and Galaxy Investment Partners as well as new investors such as Falcon Edge Capital and Pura Vida Pro were also … Read more